Vimarsana
Biggest News Aggregation in the World

Page 27 - Genentech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genentech Today - Breaking & Trending Today

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 - Vimarsana News

BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024

MAINZ, Germany, April 22, 2024 -- BioNTech SE will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally, the Company will host a conference call and...

Layoffs, vacancies continue in San Mateo County - Vimarsana News

Layoffs, vacancies continue in San Mateo County

Despite financial boons to the region’s artificial intelligence and biotechnology sector, accompanying jobs in the county are slow to pick up so far this year, as layoffs and continuously high

Alectinib Approved for ALK-Positive Adjuvant NSCLC - Vimarsana News

Alectinib Approved for ALK-Positive Adjuvant NSCLC

The approval makes alectinib the first ALK inhibitor approved for early-stage NSCLC.

Related Topics:
Drug Administration
Review Finds Anti-BCMA CAR T-Cell Therapy Effective in Patients With MM - Vimarsana News

Review Finds Anti-BCMA CAR T-Cell Therapy Effective in Patients With MM

The analysis also found the therapy has a manageable safety profile.

Source: ajmc.com
ProQR Therapeutics N : AGM 2024 Explanatory Notes - Vimarsana News

ProQR Therapeutics N : AGM 2024 Explanatory Notes

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V. Explanatory Notes to the Agenda ProQR Therapeutics N.V. | Zernikedreef 9...